Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 4/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24716126 | 0.82 | CYP11B1 (0.38) | CYP11B1CYP11B2MEN1KMT2ADGAT1 | |
| SCHEMBL25168715 | 0.73 | DGAT1 (0.45) | DGAT1 | |
| SCHEMBL30278641 | 0.73 | DGAT1 (0.45) | DGAT1 | |
| SCHEMBL30278642 | 0.69 | ALDH1A1 (0.39) | MEN1KMT2ADGAT1PTGS1PTGS2 | |
| SCHEMBL23142381 | 0.69 | ALDH1A1 (0.39) | MEN1KMT2ADGAT1PTGS1PTGS2 | |
| SCHEMBL30060553 | 0.67 | ATM (0.54) | CYP11B1CYP11B2MEN1KMT2ACA12 | |
| SCHEMBL28395012 | 0.67 | ATM (0.54) | CYP11B1CYP11B2MEN1KMT2ACA12 | |
| SCHEMBL23142357 | 0.62 | NPC1 (0.53) | MEN1KMT2ADGAT1HPGDNPSR1 | |
| SCHEMBL10423590 | 0.61 | MEN1 (0.57) | CYP11B1CYP11B2MEN1KMT2ACA12 | |
| SCHEMBL17896647 | 0.61 | CYP11B2 (0.67) | CYP11B1CYP11B2USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240270712-A1 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | NIHON NOHYAKU CO., LTD. (JP) | 2024-08-15 | — | — | US | disclosed |
| EP-4349824-A1 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | Nihon Nohyaku Co., Ltd. (JP) | 2024-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240270712-A1 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | NHERF1, IL4I1, ZYX | CYP11B1 1336/4885CYP11B2 1291/4885MEN1 4130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.